Antiretroviral therapy and HIV-associated cancers: Antiangiogenic effect of efavirenz on chick chorioallantoic membrane

Autor: Margot J. Hosie, Clement Penny, Rosie Thecla McNeil
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Zdroj: Tropical Journal of Pharmaceutical Research; Vol 16, No 11 (2017); 2741-2747
ISSN: 1596-5996
1596-9827
Popis: Purpose: To investigate the anti-angiogenic effect of efavirenz in chick chorioallantoic membrane (CAM). Methods: Fertile eggs of the domestic fowl (Gallus gallus, variant Domesticus) were used as the in vivo vascular test environment. Experimental groups were VEGF, thalidomide (negative control), efavirenz (test drug), control 1 (treated with diluent) and control 2 (no treatment). CAM photographs were taken using a microscope camera. CAM blood vessels were scored as either “present” or “absent”. Results: There was association between treatment drugs and growth of CAM blood vessels (p < 0.05) as follows: control 1 – 100 %, control 2 – 67 %, VEGF - 83 %, thalidomide - 17 %, and efavirenz - 0 % (n = 30). Although efavirenz had absolute anti-angiogenicity and presented as a potential anti-cancer drug, there was no significant difference between the anti-angiogenicity of efavirenz (100 %) and thalidomide (83 %) (F = 1.000, p = 0.341). Conclusion : Being a first-line drug in both HAART and combination treatment of HIV-1, efavirenz may be responsible for spontaneous resolution of secondary cancers in HIV-infected patients on HAART regimen. Keywords : Efavirenz, HIV, Cancers, Angiogenesis, Chick chorioallantoic membrane
Databáze: OpenAIRE